1.24. Analysis.
Comparison 1 Ezetimibe plus other lipid‐modifying drugs vs other lipid‐modifying drugs alone or plus placebo, Outcome 24 Adverse events ‐ hepatopathy (sensitivity analysis: only including low risk of bias studies).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.